Navigation Links
Drugs Used to Fight Cholesterol Could Also Help in Mesothelioma Treatment, Baron and Budd Reports
Date:8/14/2014

DALLAS (PRWEB) August 15, 2014

A team of Korean researchers has found that a drug normally used to lower cholesterol could also help a commonly used chemotherapy medication kill malignant mesothelioma cells, the mesothelioma law firm of Baron and Budd reports. The results of the research team’s work was published in the latest issue of the International Journal of Oncology. (http://www.ncbi.nlm.nih.gov/pubmed/25096993)

Cholesterol-lowering drugs, or statins, such as simvastatin have been shown to cause apoptosis, or the killing of certain types of mesothelioma cells. When they paired simvastatin with the chemotherapy drug pemetrexed, the researchers found the combination was more effective than the use of either drug on its own. According to the study, the combination increased the production of ROS, or reactive oxygen species. ROS is an indicator of cellular stress wherein the mitochondria – the portion of a cell that produces energy – is weakened.

The research team found that the simvastatin and pemetrexed combination activated a molecule called Bim that accelerates the process of apoptosis. If the findings of the team are confirmed by further laboratory study, the combination will be tested in mesothelioma patients.
The most widely accepted chemotherapy treatment, for malignant pleural mesothelioma patients is currently a combination of pemetrexed with cisplatin. However, that has only proven to be moderately successful. Typically, mesothelioma patients undergo different types of treatments, including chemotherapy, surgery and drug therapy.

“We applaud and appreciate the incredibly hard work these and other medical professionals are doing in order to treat this horrible disease,” said Russell Budd, co-founder and managing director of the mesothelioma law firm of Baron and Budd.

Mesothelioma can occur after the inhalation or ingestion of asbestos fibers. If you or someone close to you developed the disease after being exposed to asbestos, you may be able to pursue legal action. Please contact the national mesothelioma law firm of Baron and Budd to learn more. Call us at 1-866-855-1229 or visit our website at http://www.fightmesothelioma.com to learn more.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12094588.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pharmacy Robots Linked to Bacterial Contamination of Drugs
2. Penn study cautions use of drugs to block niacin flush
3. Urinary Incontinence Drugs May Be More Trouble Than Theyre Worth
4. Discovery could help to develop drugs for organ transplant and cancer patients
5. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
6. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
7. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
8. Seniors Stop Taking Heart Drugs In Medicare Donut Hole
9. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
10. About 1 baby born each hour addicted to opiate drugs in U.S., U-M study shows
11. Blood pressure drugs linked with lower PTSD symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology: